127 related articles for article (PubMed ID: 10523161)
1. Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection.
Arranz Caso JA; Sanchez Mingo C; Garcia Tena J
N Engl J Med; 1999 Oct; 341(16):1239-40. PubMed ID: 10523161
[No Abstract] [Full Text] [Related]
2. Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors.
Carbonara S; Fiorentino G; Serio G; Maggi P; Ingravallo G; Monno L; Bruno F; Coppola S; Pastore G; Angarano G
J Infect; 2001 May; 42(4):251-6. PubMed ID: 11545567
[TBL] [Abstract][Full Text] [Related]
3. Lack of response of thrombocytopenia associated with human immunodeficiency virus to triple antiretroviral therapy.
Domingo P; Coma E; Muñiz-Díaz E
Arch Intern Med; 1997 Dec 8-22; 157(22):2669-70. PubMed ID: 9580146
[No Abstract] [Full Text] [Related]
4. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
5. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
[No Abstract] [Full Text] [Related]
6. Response of HIV-associated thrombocytopenia to triple agent antiretroviral therapy.
Walsh JC; Costello CE; Nelson MR
AIDS; 1997 Mar; 11(3):399-400. PubMed ID: 9147442
[No Abstract] [Full Text] [Related]
7. Antiretroviral therapy in human immunodeficiency virus-infected individuals.
Spooner KM
Adv Intern Med; 1998; 43():373-402. PubMed ID: 9506188
[No Abstract] [Full Text] [Related]
8. Data in from first head-to-head protease inhibitor.
AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
[No Abstract] [Full Text] [Related]
9. Anti-HIV effects of nelfinavir reported after ten months of combination therapy.
AIDS Patient Care STDS; 1997 Aug; 11(4):289-90. PubMed ID: 11361848
[No Abstract] [Full Text] [Related]
10. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
11. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.
Revankar SG; Sanche SE; Dib OP; Caceres M; Patterson TF
AIDS; 1998 Dec; 12(18):2511-3. PubMed ID: 9875598
[No Abstract] [Full Text] [Related]
12. Study shows three drugs better than two.
AIDS Alert; 1997 Apr; 12(4):39. PubMed ID: 11364145
[TBL] [Abstract][Full Text] [Related]
13. Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy.
Galli M; Balotta C; Meroni L; Colombo MC; Papagno L; Bagnarelli P; Testa L; Varchetta S; Colombo L; Moroni M; d'Arminio Monforte A; Clerici M; Clementi M
AIDS; 1998 Dec; 12(18):2500-2. PubMed ID: 9875591
[No Abstract] [Full Text] [Related]
14. [Antiretroviral therapy in patients infected with HIV-1].
Corti ME
Medicina (B Aires); 1998; 58 Suppl 1():49-56. PubMed ID: 9674248
[No Abstract] [Full Text] [Related]
15. Antiretroviral therapy, 1998.
Postic B; Horvath JA; Green PA; Bryan CS
J S C Med Assoc; 1998 May; 94(5):207-17. PubMed ID: 9609963
[TBL] [Abstract][Full Text] [Related]
16. Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection.
Ananworanich J; Phanuphak N; Nuesch R; Apateerapong W; Rojnuckarin P; Ubolyam S; Phanuphak P; Ruxrungtham K
Clin Infect Dis; 2003 Sep; 37(5):723-5. PubMed ID: 12942407
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
[TBL] [Abstract][Full Text] [Related]
18. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
19. [HIV-related thrombocytopenias].
Mannucci PM; Gringeri A
Ann Ital Med Int; 2000; 15(1):20-7. PubMed ID: 10842888
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
